945259-94-9 Usage
Uses
Used in Pharmaceutical Synthesis:
Tert-butyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate is used as a key intermediate for the synthesis of pharmaceuticals. Its presence in the molecule allows for the protection of amines, which is crucial in multi-step synthesis processes to prevent unwanted side reactions.
Used in Agrochemical Production:
In the agrochemical industry, tert-butyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate is used as a building block for the creation of agrochemicals. Its boron-containing structure can participate in reactions that lead to the formation of active ingredients in pesticides and other agricultural products.
Used in Fine Chemicals Synthesis:
Tert-butyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate is employed as a versatile intermediate in the synthesis of fine chemicals. Its unique structure and reactivity enable the production of a wide range of specialty chemicals used in various industries, such as fragrances, dyes, and coatings.
Check Digit Verification of cas no
The CAS Registry Mumber 945259-94-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,5,2,5 and 9 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 945259-94:
(8*9)+(7*4)+(6*5)+(5*2)+(4*5)+(3*9)+(2*9)+(1*4)=209
209 % 10 = 9
So 945259-94-9 is a valid CAS Registry Number.
945259-94-9Relevant academic research and scientific papers
DIMETHYLAMINOETHANOL SALT OF A GLP-1 RECEPTOR MODULATOR
-
, (2018/04/17)
Crystalline 2-hydroxy-N,N-dimethylethanaminium 1 -(2-(5-(tert-butyl) -thiophene-2-carboxamido)-3-(4-(5-(4'-ethyl-[1,1'-bi(cyclohexan)]-3- en-4-yl)pyrimidin-2-yl)phenyl)propanoyl)azetidine-3-carboxylate salt, and methods related to synthesis and therapeuti
NOVEL GLP-1 RECEPTOR MODULATORS
-
, (2016/02/09)
Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36), GLP-1(9-36), and oxyntomodulin, or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where "?" represents either or both the R and S form of the compound): where A, B, C, R1, R2, R3, R4, R5, n, p and q are as defined herein.
